Home > Offer to Sell > Pharmaceuticals and Biochemicals > Others > Esomeprazole sodium/CAS 161796-78-7
Esomeprazole sodium/CAS 161796-78-7
Inquiry
| Post Date: | Feb 25,2015 |
| Expiry Date: | Feb 25,2016 |
| Detailed Description: |
Cas No. :161796-78-7
Quantity: 20Metric Tons Specs:Purity≧98% Payment Method: T/T in advance Wuliangye Group Yibin Pharmaceutical Co.,Ltd was established in 1969 and covers an total area of over 220000 square meters. Yibin Pharmaceutical Co., Ltd is a GMP approved enterprise and mainly produced formulation of Chinese medicine, APIs, biological agents, and pharmaceutical intermediates. 1、Pharmaceutical manufacturer with super quality by reasonable price. 2、Fast delivery by safe express way to all the country. 3、Has a number of highlty qualified engineers and experts to provide guidance for reagents. 4、Free samples can be provided. 5、Fast delivery by safe express way to all the country. Welcome to contact us for more products information and requirement, I will send our product list for your choose. Looking forward to our long term cooperation. Synonyms: 1H-BENZIMIDAZOLE,5-METHOXY-2-[[(4-METHOXY-3,5-DIMETHYL-2-PYRIDINYL)METHYL]SULFINYL]-, SODIUM SALT; ESOMEPRAZOLE SODIUM; Esomeprazoleandsalts; 5-Methoxy-2- ((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl-1H-benzimidazole sodium salt;(S)-OMeprazole sodiuM; SodiuM(S)-6- Methoxy-2-(((4 -Methoxy-3,5-diMethylpyridin-2-yl)Methyl)sulfinyl)benzo[d]iMidazol-1-ide;odiuM(R)-6-Methoxy-2-(((4-Methoxy-3,5-diMethylpyridin-2-yl)Methyl)sulfinyl)benzo[d]iMidazol-1-ide Main functions: 1 indications editing of gastroesophageal reflux disease (GERD) - prevent erosive reflux esophagitis therapy has been cured of esophagitis in patients with long-term maintenance treatment of gastroesophageal reflux disease recurrence (GERD) symptom control and appropriate antimicrobial therapy combined with medication for eradication of Helicobacter pylori, and - Healing correlation of Helicobacter pylori infection and Prevention - related duodenal ulcer with Helicobacter pylori peptic ulcer recurrence. Esomeprazole is S- optical isomer of omeprazole, is the first global isomers of proton pump inhibitor (PPI), through specific inhibition of gastric parietal cell proton pump to reduce gastric acid secretion. By a large number of clinical experiments and drug research confirmed: the maintenance of pH>4 in stomach for longer, acid suppression efficiency is higher, the efficacy is better than the former two generation PPI, the individual difference is small. As a new generation of PPI, has been widely used in clinical treatment of many acid related diseases. Proton pump inhibitor (PPI) is the drug of choice for treatment of esophageal gastric peptic ulcer and reflux disease in acid related diseases. At present, clinical on commonly used PPI omeprazole, lansoprazole, ray Bella azole, pantoprazole and esomeprazole 5. Omeprazole as the first PPI drug, its efficacy in the treatment of acid related diseases has been endorsed unanimously. Esomeprazole, commodity name Nexium (Nexium), is a single heterogeneous omeprazole, namely (S) - isomer. Because of its metabolic advantage, esomeprazole than omeprazole has higher bioavailability and more consistent pharmacokinetics, put the drug where proton pump increases, acid suppression effect is better than that of other PPI. Although oral esomeprazole can obtain good clinical results, but in some patients, such as patients in the recovery stage and the surgery difficulty swallowing, vomiting, acute hemorrhage of upper digestive tract, oral become a feasible way of administration of intravenous route of administration, it has become an inevitable choice. Therefore, PPI does not apply to oral dosing in patients with esomeprazole sodium for injection. Molecular formula：C17H18N3NaO3S Molecular weight：369.41g/mol Boiling point: 600℃ at 760mmHg Flash point: 316.7℃ Appearance: white or light yellow powder Package: 25kg/drum Assay: ≧98% |
| CAS Registry Number: | 161796-78-7 |
| Synonyms: | ;1H-benzimidazole, 5-Methoxy-2-[[(4-Methoxy-3,5-dimethyl-2-PYRIDINYL)methyl]sulfinyl]-, sodium salt;Esomeprazoleandsalts;5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl-1H-benzimidazole sodium salt;sodium 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide;sodium 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-2,3-dihydrobenzimidazol-1-ide;bis[5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]benzimidazol-1-yl]magnesium;Esomeprazole Na; |
| Molecular Formula: | C34H36MgN6O6S2 |
| Molecular Weight: | 713.1212 |
| Molecular Structure: | 
|
| Company: | Wuliangye Group Yibin Pharmaceutical Co.,Ltd. [ China ] |
| Contact: | Pointy |
| Tel: | +86-831-5109854 |
| Fax: | +86-831-5109807 |
| Email: | yibinpharma@163.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
